Crossref
Prescribing changes following fluoroquinolone safety warning
Drug and Therapeutics Bulletin · 2024-07 · 62 (7) · 100-100
DOI: 10.1136/dtb.2024.000035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Therapeutics Bulletin, online erschienen am 30.05.2024. Hauptthemen laut MEDLINE: Fluoroquinolones, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
FluoroquinolonesAnti-Bacterial AgentsHumansPractice Patterns, Physicians'Drug LabelingUnited StatesDrug Prescriptions
Stichwörter der Autor:innen
Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and Evaluation
Substanzen
FluoroquinolonesAnti-Bacterial Agents
Zitieren
APA
(2024). Prescribing changes following fluoroquinolone safety warning. Drug and Therapeutics Bulletin, 62(7), 100-100. https://doi.org/10.1136/dtb.2024.000035
Vancouver
Prescribing changes following fluoroquinolone safety warning. Drug and Therapeutics Bulletin. 2024;62(7):100-100. doi:10.1136/dtb.2024.000035
BibTeX
@article{euvimed2024,
title = {Prescribing changes following fluoroquinolone safety warning},
journal = {Drug and Therapeutics Bulletin},
year = {2024},
volume = {62},
number = {7},
pages = {100--100},
doi = {10.1136/dtb.2024.000035}
}
EUVIMED